The ‘Stage, Size, Grade and Necrosis’ score is more accurate than the University of California Los Angeles Integrated Staging System for predicting cancer‐specific survival in patients with clear cell renal cell carcinoma

No abstract is available for this paper.

• Publication year

  2009

• Venue

  BJU International

• Publication date

  2009-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1464-410X.2008.07901.xPMID 18782313
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mathematical Models for Prognostic Prediction in Patients with Renal Cell Carcinoma

  2008cited by this paper
• Multi-institutional validation of a new renal cancer-specific survival nomogram.

  2007cited by this paper
• Protein Expression Profiles in Renal Cell Carcinoma: Staging, Prognosis, and Patient Selection for Clinical Trials

  2007cited by this paper
• Present strategies in the treatment of metastatic renal cell carcinoma: an update on molecular targeting agents

  2007cited by this paper
• Adjuvant therapy of renal cell carcinoma.

  2006cited by this paper
• Low predictive accuracy of the Kattan postoperative nomogram for renal cell carcinoma recurrence in a population of French patients

  2006cited by this paper
• External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma.

  2006cited by this paper
• A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma.

  2005cited by this paper
• Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy

  2005cited by this paper
• Prognostic significance of morphologic parameters in renal cell carcinoma

  2004cited by this paper
• Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study.

  2004cited by this paper
• Multi-institutional validation of a symptom based classification for renal cell carcinoma.

  2004cited by this paper
• Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population.

  2003cited by this paper
• Mathematical model to predict individual survival for patients with renal cell carcinoma.

  2002cited by this paper
• AJCC Cancer Staging Manual. 6th ed

  2002cited by this paper
• An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score.

  2002cited by this paper
• Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma.

  2002cited by this paper
• A postoperative prognostic nomogram for renal cell carcinoma.

  2001cited by this paper
• Classification of renal cell carcinoma

  1997cited by this paper
• The Heidelberg classification of renal cell tumours

  1997cited by this paper
• The meaning and use of the area under a receiver operating characteristic (ROC) curve.

  1982cited by this paper
• Prognostic significance of morphologic parameters in renal cell carcinoma

  1982cited by this paper

• In Pursuit of KI-RADS: Toward a Single, Evidence-based Imaging Classification of Renal Masses.

  2025cites this paper
• Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers: an update after ISUP/WHO 2022 classification

  2025cites this paper
• MtDNA copy number enrichment is associated with poor prognosis and eosinophilic morphology in clear cell renal cell carcinoma

  2025cites this paper
• Radiomics-based tumor heterogeneity augments clinicopathological models for predicting recurrence in high-risk clear cell renal cell carcinoma after nephrectomy

  2025cites this paper
• Prediction of metastatic risk of renal clear cell carcinoma based on CT radiomics analysis

  2025cites this paper
• The interpretable CT-based vision transformer model for preoperative prediction of clear cell renal cell carcinoma SSIGN score and outcome

  2025cites this paper
• Machine Learning-Enabled Fuhrman Grade in Clear-cell Renal Carcinoma Prediction Using Two-dimensional Ultrasound Images.

  2024cites this paper
• Tumor contour irregularity on preoperative CT predicts prognosis in renal cell carcinoma: a multi-institutional study

  2024cites this paper
• Sub-regional Radiomics Analysis for Predicting Metastasis Risk in Clear Cell Renal Cell Carcinoma: A Multicenter Retrospective Study.

  2024cites this paper
• Multimodal data integration using machine learning to predict the risk of clear cell renal cancer metastasis: a retrospective multicentre study

  2024cites this paper
• A Comprehensive Correlation of Clinicopathologic Prognostic Factors in Malignant Adult Renal Tumors: A Single Institutional Study

  2024cites this paper
• A preoperative CT-based deep learning radiomics model in predicting the stage, size, grade and necrosis score and outcome in localized clear cell renal cell carcinoma: A multicenter study.

  2023cites this paper
• Serum extracellular vesicles derived hsa-miR-320d as an indicator for progression of clear cell renal cell carcinoma

  2023cites this paper
• The radiomics-based tumor heterogeneity adds incremental value to the existing prognostic models for predicting outcome in localized clear cell renal cell carcinoma: a multicenter study

  2022cites this paper
• Risk of recurrence after nephrectomy: Comparison of predictive ability of validated risk models.

  2022cites this paper
• Novel VHL substrate targets SFMBT1 and ZHX2 may be important prognostic predictors in patients with ccRCC

  2021cites this paper
• MR Imaging Radiomics Analyses for Prediction of High Grade Histology and Necrosis in Clear Cell Renal Cell Carcinoma: Preliminary Experience

  2021cites this paper
• Risk models for recurrence and survival after kidney cancer: a systematic review

  2021cites this paper
• A CT-Based Radiomics Nomogram Integrated With Clinic-Radiological Features for Preoperatively Predicting WHO/ISUP Grade of Clear Cell Renal Cell Carcinoma

  2021cites this paper
• Comprehensive analysis of the expression and prognosis for COL4A family genes in kidney renal clear cell carcinoma

  2021cites this paper
• Leibovich score is the optimal clinico-pathological system associated with recurrence of non-metastatic clear cell renal cell carcinoma.

  2021cites this paper
• Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers

  2021cites this paper
• Nuclear and cytosolic pS727-STAT3 levels correlate with overall survival of patients affected by clear cell renal cell carcinoma (ccRCC)

  2021cites this paper
• Identification of DNA methylation signatures associated with poor outcome in lower-risk Stage, Size, Grade and Necrosis (SSIGN) score clear cell renal cell cancer

  2021cites this paper
• Magnetic Resonance Imaging Radiomics Analyses for Prediction of High-Grade Histology and Necrosis in Clear Cell Renal Cell Carcinoma: Preliminary Experience.

  2020cites this paper
• A practical nomogram for predicting cancer-specific survival in patients with clear-cell renal cell carcinoma

  2020cites this paper
• 8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness

  2020cites this paper
• The Clinicopathological Risk Factors in Renal Cell Cancer for the Oncological Outcomes Following Nephron-Sparing Surgery: A PRISMA Systematic Review and Meta-Analysis

  2020cites this paper
• Prognostic analysis of postoperative clinically nonmetastatic renal cell carcinoma

  2019cites this paper
• Epidemiology, Screening, and Clinical Staging

  2019cites this paper
• Outcomes: Prognostic Factors, Models, and Algorithms

  2019cites this paper
• Assessment of the extracellular volume fraction for the grading of clear cell renal cell carcinoma: first results and histopathological findings

  2019cites this paper
• The Effect of Framingham Score on the Oncological Outcomes in Localized (T1-T2 Stage) Renal Cell Carcinoma Patients

  2019influential citation
• DNA methylation-based classification and identification of renal cell carcinoma prognosis-subgroups

  2019cites this paper
• Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients

  2019cites this paper
• Identification of METTL14 in Kidney Renal Clear Cell Carcinoma Using Bioinformatics Analysis

  2019cites this paper
• Author Correction: Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients

  2019cites this paper
• An Integrated Score and Nomogram Combining Clinical and Immunohistochemistry Factors to Predict High ISUP Grade Clear Cell Renal Cell Carcinoma

  2018cites this paper
• Tumor Multicomponent Targeting Polymer-Lipid Hybrid Nanoparticles To Overcome Drug Resistance In Renal Cell Carcinoma

  2018cites this paper
• Adjuvant therapy in renal cell carcinoma: does higher risk for recurrence improve the chance for success?

  2018cites this paper
• [Current guideline-oriented follow-up of small renal masses : Applied risk scores and future outlook].

  2018cites this paper
• Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma

  2018cites this paper
• Aktuelle leitliniengerechte Nachsorge kleiner Nierentumoren

  2018cites this paper
• Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients.

  2017cites this paper
• Identification and validation of an eight‐gene expression signature for predicting high Fuhrman grade renal cell carcinoma

  2017cites this paper
• Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805

  2017cites this paper
• Validation of a new prognostic model to easily predict outcome in renal cell carcinoma: the GRANT score applied to the ASSURE trial population

  2017cites this paper
• Cannabinoid receptor 2 as a novel target for promotion of renal cell carcinoma prognosis and progression

  2017cites this paper
• PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH CHEMOTHERAPY

  2016cites this paper
• High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma

  2016cites this paper
• Tumour suppressor gene (CDKNA2) status on chromosome 9p in resected renal tissue improves prognosis of localised kidney cancer

  2016cites this paper
• Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma

  2016cites this paper
• A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma

  2015cites this paper
• Temporal Identification of Dysregulated Genes and Pathways in Clear Cell Renal Cell Carcinoma Based on Systematic Tracking of Disrupted Modules

  2015cites this paper
• Independent Predictors of Clinical Outcomes and Prediction Models for Renal Tumor Pathology

  2015cites this paper
• Clinico-pathological prognostic factors of renal cell carcinoma: A 15-year review from a single center in Greece

  2014cites this paper
• Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery

  2014cites this paper
• Prognostic Factors for Localized Renal Cell Carcinoma

  2013cites this paper
• Análisis de sobrevida y complicaciones en 97 pacientes con metástasis óseas tratados quirúrgicamente

  2013cites this paper
• Adjuvant Therapy in Renal Cell Carcinoma—Past, Present, and Future☆

  2013cites this paper
• A Novel Grading System for Clear Cell Renal Cell Carcinoma Incorporating Tumor Necrosis

  2013cites this paper
• Factor‐inhibiting hypoxia‐inducible factor expression in patients with high‐risk locally advanced renal cell carcinoma and its relationship with tumor progression

  2013cites this paper
• The future of adjuvant therapy for renal cell carcinoma

  2012cites this paper
• A review of integrated staging systems for renal cell carcinoma.

  2012cites this paper
• Adjuvant Therapy for Renal Cell Carcinoma

  2012cites this paper
• Systemic adjuvant therapies in renal cell carcinoma

  2012cites this paper
• Integrative genomic analyses of sporadic clear cell renal cell carcinoma define disease subtypes and potential new therapeutic targets.

  2012cites this paper
• Renal cellcarcinoma: advances in minimally invasive treatments and outcome prediction

  2012cites this paper
• Malignant Renal Tumors

  2012cites this paper
• Treatment of Locally Advanced Renal Cell Carcinoma

  2012cites this paper
• Molecular and Cellular Pathobiology Integrative Genomic Analyses of Sporadic Clear Cell Renal Cell Carcinoma De fi ne Disease Subtypes and Potential New Therapeutic Targets

  2011cites this paper
• Neoadjuvant and adjuvant strategies in renal cell carcinoma: more questions than answers

  2011cites this paper
• The European Union Interreg Program: Italian-Albanian experience with kidney transplants

  2011cites this paper
• Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.

  2011cites this paper
• Expression of nuclear FIH independently predicts overall survival of clear cell renal cell carcinoma patients.

  2010cites this paper
• Renal cell cancer: state of the art in adjuvant therapy.

  2010cites this paper
• Factors affecting outcome in renal cell carcinoma

  2010cites this paper
• Combined renal sinus fat and perinephric fat renal cell carcinoma invasion has a worse prognosis than either alone.

  2010cites this paper
• Comparison of the UCLA Integrated Staging System and the Leibovich score in survival prediction for patients with nonmetastatic clear cell renal cell carcinoma.

  2010cites this paper
• Adjuvant and neoadjuvant small-molecule targeted therapy in high-risk renal cell carcinoma

  2009cites this paper
• The role of lymphadenectomy in renal cell carcinoma

  2009cites this paper
• Complexity of tumor vasculature in clear cell renal cell carcinoma

  2009cites this paper
• A comparative study of quality of life issues relating to open versus laparoscopic nephrectomy: a prospective pragmatic study.

  2009cites this paper
• Renal cell carcinoma: assessment of key pathologic prognostic parameters and patient characteristics in 47,909 cases using the National Cancer Data Base.

  2009cites this paper
• Biomarkers in renal cell carcinoma

  2009cites this paper
• Facteurs pronostiques des carcinomes à cellules rénales aux stades localisés et métastatiques

  2009cites this paper